Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Buy
64
THNR Quote, Financials, Valuation and Earnings
Last price:
$24.92
Seasonality move
:
-0.66%
Day range:
$25.22 - $25.25
52-week range:
$18.56 - $26.27
Dividend yield:
0.87%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
652
Avg. volume:
1.4K
1-year change:
4.4%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Amplify Weight Loss Drug & Treatment ETF has -- downside to fair value with a price target of -- per share.
THNR vs. S&P 500
-
Over the past 5 trading days, Amplify Weight Loss Drug & Treatment ETF has underperformed the S&P 500 by -3.35% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Amplify Weight Loss Drug & Treatment ETF does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Amplify Weight Loss Drug & Treatment ETF has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Amplify Weight Loss Drug & Treatment ETF reported revenues of --.
Earnings Growth
-
Amplify Weight Loss Drug & Treatment ETF has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Amplify Weight Loss Drug & Treatment ETF reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-08 | 2024-12-08 | 2024-12-08 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2021-12-08 | 2022-12-08 | 2023-12-08 | 2024-12-08 | ||
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | -- | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-08 | 2024-12-08 | 2024-12-08 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
THNR
Sector
Market Cap
--
--
Price % of 52-Week High
95.99%
--
Dividend Yield
0.87%
--
Shareholder Yield
--
--
1-Year Price Total Return
4.4%
--
Beta (5-Year)
--
--
Dividend yield:
0.87%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$25.60
200-day SMA
Buy
Level
$22.85
Bollinger Bands (100)
Buy
Level
22.64 - 24.58
Chaikin Money Flow
Sell
Level
-64.1K
20-day SMA
Buy
Level
$25.11
Relative Strength Index (RSI14)
Buy
Level
56.68
ADX Line
Buy
Level
32.59
Williams %R
Buy
Level
-81.7597
50-day SMA
Buy
Level
$24.23
MACD (12, 26)
Buy
Level
0.42
25-day Aroon Oscillator
Buy
Level
64
On Balance Volume
Sell
Level
-52.2K
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (3)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Stock Forecast FAQ
In the current month, THNR has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The THNR average analyst price target in the past 3 months is --.
-
Where Will Amplify Weight Loss Drug & Treatment ETF Stock Be In 1 Year?
According to analysts, the consensus estimate is that Amplify Weight Loss Drug & Treatment ETF share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Amplify Weight Loss Drug & Treatment ETF?
Analysts are divided on their view about Amplify Weight Loss Drug & Treatment ETF share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Amplify Weight Loss Drug & Treatment ETF is a Sell and believe this share price will rise from its current level to --.
-
What Is Amplify Weight Loss Drug & Treatment ETF's Price Target?
The price target for Amplify Weight Loss Drug & Treatment ETF over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is THNR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Amplify Weight Loss Drug & Treatment ETF is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of THNR?
You can purchase shares of Amplify Weight Loss Drug & Treatment ETF via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Amplify Weight Loss Drug & Treatment ETF shares.
-
What Is The Amplify Weight Loss Drug & Treatment ETF Share Price Today?
Amplify Weight Loss Drug & Treatment ETF was last trading at $24.92 per share. This represents the most recent stock quote for Amplify Weight Loss Drug & Treatment ETF. Yesterday, Amplify Weight Loss Drug & Treatment ETF closed at $25.22 per share.
-
How To Buy Amplify Weight Loss Drug & Treatment ETF Stock Online?
In order to purchase Amplify Weight Loss Drug & Treatment ETF stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get THNR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
THNR
Sector
P/E ratio
--
--
PEG ratio
--
--
P/B ratio
--
--
Price / LTM sales
--
--
Growth Metrics
THNR
Sector
Revenue growth
--
--
Earnings growth
--
--
Revenue (5-year growth)
--
--
Earnings forecast
--
--
Profitability
THNR
Sector
Profitability FY 2025
--
--
Return on invested capital
--
--
Return on assets
--
--
Return on equity
--
--
Earnings Date
Last Earnings Date
Dec
8
Next Earnings Date
Dec
8
Estimated Next Earnings Date
Mar
9
Balance Sheet
THNR
Sector
Total cash
--
--
Short term investments
--
--
Total assets
--
--
Long term debt
--
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
50
TGL alert for Dec 8
Treasure Global, Inc. [TGL] is up 3.46% over the past day.
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 47.95% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 10.69% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
